Business · 30/04/20011 min read

Abbott Laboratories' Sarafloxacin for Poultry; Withdrawal of Approval of NADAs

The US Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADAs) sponsored by Abbott Laboratories, which would have allowed the use of sarafloxacin to treat poultry, and amending the animal drug regulations accordingly.